phenylalanine and Diarrhea

phenylalanine has been researched along with Diarrhea in 76 studies

Research

Studies (76)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (13.16)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	56 (73.68)	24.3611
2020's	10 (13.16)	2.80

Authors

Authors	Studies
Shah, ED	1
Boinpally, R; Breen-Lyles, M; Busciglio, I; Camilleri, M; Carrothers, TJ; Maselli, D; Muslin, A; Nord, SL; Vijayvargiya, P	1
Friedenberg, FK; Piech, G; Reichenbach, ZW; Selby, A	1
Brenner, DM; Sayuk, GS	1
Black, CJ; Ford, AC; Houghton, LA	1
Andrae, DA; Covington, PS; Dove, LS; Lembo, AJ	1
Brenner, DM; Cash, BD; Elmes, SJR; Gutman, CR; Jo, E; Liu, LWC; Sayuk, GS	2
Benson, AB; Dharba, S; Joish, VN; Lapuerta, P; Sapre, D; Strosberg, J	1
Liu, R; Staller, K	1
Heidelbaugh, J; Jones, J; Kuritzky, L; Lacy, B; Lembo, A	1
Abel, JL; Brenner, DM; Burslem, K; Sayuk, GS	1
Andrae, DA; Chey, WD; Covington, PS; Dove, LS	1
Markham, A	1
Cash, BD; Chey, WD; Covington, PS; Dove, LS; Lacy, BE; Lembo, AJ	1
Keating, GM	1
Kulke, MH	1
Júdez, FJ; Vera, I	1
Frech, F; Joish, VN; Lapuerta, P	2
Barkin, JS; Croteau, R	1
Özdener, AE; Rivkin, A	1
Masab, M; Saif, MW	1
Anthony, L; Arnold, K; Bergsland, E; Caplin, M; DiBenedetti, DB; Ervin, C; Evans, E; Hörsch, D; Jackson, S; Kulke, MH; Kunz, P; Lapuerta, P; Law, L; Metz, DC; Öberg, K; Pasieka, J; Pavel, M; Pavlakis, N; Ramage, J; Yang, QM	1
Anthony, LB; Benavent, M; Fleming, D; Fleming, R; Garcia-Carbonero, R; Gross, DJ; Hörsch, D; Jiang, W; Kassler-Taub, K; Kulke, MH; Kunz, PL; Lapuerta, P; Pavel, M; Perros, P; Srirajaskanthan, R; Warner, RRP; Wason, S; Weickert, MO	1
Chandrasekharan, C; Dillon, JS	1
Barbara, G; Barbaro, MR; De Ponti, F; Dothel, G; Raschi, E	1
Anthony, LB; Bergsland, E; Caplin, ME; Grande, E; Hörsch, D; Kaltsas, G; Kittur, A; Kulke, MH; Kunz, PL; Lapuerta, P; Lombard-Bohas, C; Öberg, K; Pavel, M; Ramage, JK; Valle, JW; Weickert, MO; Welin, S; Yang, QM	1
Lyseng-Williamson, KA	1
Akbarali, HI; Dewey, WL; Komla, E; Obeng, S; Selley, DE; Stevens, DL; Wang, H; Zhang, Y; Zheng, Y	1
Kasi, PM	1
Corsetti, M; Pannemans, J	1
Abel, JL; Andrae, DA; Carson, RT	1
Chey, WD; Chuang, E; Earnest, DL; Olden, KW; Paul Nicandro, J; Shringarpure, R	1
Beaumont, JL; Cella, D; Feuilly, M; Hörsch, D; Houchard, A; Hudgens, S; Kulke, MH; Lapuerta, P; Marteau, F; Pavel, M; Ramage, J	1
Anthony, LB; Bergsland, E; Caplin, ME; Dillon, JS; Hörsch, D; Jiang, W; Kassler-Taub, K; Kulke, MH; Lapuerta, P; O'Dorisio, TM; Öberg, K; Pavel, M; Warner, RRP	1
Gunn, D; Major, GAD	1
Lai, SW	1
Benson, AB; Dharba, S; Fish-Steagall, A; Giacalone, S; Joish, VN; Kapoor, K; Lapuerta, P; Perez-Olle, R; Strosberg, J	1
Cash, BD; Covington, PS; Dove, LS; Lacy, BE; Schoenfeld, PS	2
Almenoff, JS; Andrae, D; Covington, PS; Davenport, JM; Dove, LS; Fogel, R; Lembo, A; McIntyre, G; Randall, CW	1
Andrae, DA; Covington, PS; Patrick, DL	1
Banks, P; Bergsland, E; Fleming, D; Frazier, K; Freiman, J; Jackson, J; Kulke, MH; Kvols, L; Lapuerta, P; Law, L; O'Dorisio, T; Phan, A; Sands, A; Yao, JC; Zambrowicz, B	1
Devi, LA; Dove, LS; Fujita, W; Gomes, I; McIntyre, G; Prohaska, D	1
Traynor, K	1
Garnock-Jones, KP	1
Lembo, AJ; Nee, J; Zakari, M	1
Cash, BD; Earnest, DL; Lacy, BE; Rao, T	1
Lacy, BE	1
Álvarez de la Campa, E; Colobran, R; de la Cruz, X; Martín-Nalda, A; Martínez-Gallo, M; Pujol-Borrell, R; Soler-Palacín, P	1
Andrae, DA; Covington, PS; Davenport, JM; Dove, LS; Lacy, BE; Lembo, AJ; Lopez, R; McIntyre, G; Schey, R; Turner, L; Zuckerman, MJ	1
Dickson, I	1
Rivkin, A; Rybalov, S	1
Storr, M	1
Auguste, P; Boehm, KA; Gelhorn, HL; Jackson, J; Jackson, S; Kostelec, J; Kulke, MH; Lapuerta, P; Law, L; O'Dorisio, T; Yang, QM	1
Abenavoli, L; Gasbarrini, A; Ianiro, G; Laterza, L; Scarpellini, E; Tack, J	1
Lacy, BE; Moreau, JC	1
Talley, NJ	1
Weber, HC	1
Anthony, LB; Banks, P; Bergsland, E; Caplin, ME; Fleming, D; Grande, E; Hörsch, D; Jackson, S; Kulke, MH; Kunz, PL; Lapuerta, P; Lombard-Bohas, C; Öberg, K; Pavel, M; Sands, AT; Valle, JW; Warner, RR; Welin, S; Zambrowicz, B	1
Cash, BD; Covington, PS; Dove, LS; Fant, RV; Henningfield, JE	1
Camilleri, M	1
Creppy, E; Dirheimer, G; Röschenthaler, R; Schlegel, M	1
Ball, RO; Bayley, HS	1
Grahame-Smith, DG	1
Duran, M; Ketting, D; van der Heiden, C; Wadman, SK; Wauters, EA	1
Donlon, J; Fottrell, PF	1
Healy, PJ	1
Bianchine, JR; Satterlee, WG; Serpick, A	1
Levine, RJ; Vaidya, AB	1

Reviews

23 review(s) available for phenylalanine and Diarrhea

Article	Year
Pathophysiology, Differential Diagnosis, and Treatment of Diabetic Diarrhea. Digestive diseases and sciences, 2019, Volume: 64, Issue:12 Topics: Antidiarrheals; Autonomic Nervous System Diseases; Blind Loop Syndrome; Celiac Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diagnosis, Differential; Diarrhea; Diphenoxylate; Enteric Nervous System; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Gastrointestinal Motility; Hypoglycemic Agents; Imidazoles; Inflammation; Inflammatory Bowel Diseases; Interstitial Cells of Cajal; Intestinal Absorption; Intestinal Mucosa; Irritable Bowel Syndrome; Loperamide; Neuroglia; Non-Nutritive Sweeteners; Oxidative Stress; Phenylalanine; Serotonin 5-HT3 Receptor Antagonists	2019
Current US Food and Drug Administration-Approved Pharmacologic Therapies for the Treatment of Irritable Bowel Syndrome with Diarrhea. Advances in therapy, 2020, Volume: 37, Issue:1 Topics: Adult; Carbolines; Diarrhea; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine; Quality of Life; Rifaximin; United States; United States Food and Drug Administration	2020
Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives. Drug design, development and therapy, 2020, Volume: 14 Topics: Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Patient Selection; Phenylalanine	2020
Eluxadoline: A Review in Diarrhoea-Predominant Irritable Bowel Syndrome. Drugs, 2017, Volume: 77, Issue:9 Topics: Adult; Constipation; Diarrhea; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Male; Middle Aged; Phenylalanine; Quality of Life; Randomized Controlled Trials as Topic; Receptors, Opioid, delta	2017
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. The SEPD perspective. Revista espanola de enfermedades digestivas, 2017, Volume: 109, Issue:11 Topics: Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine; Quality of Life; Randomized Controlled Trials as Topic	2017
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome. Drug design, development and therapy, 2017, Volume: 11 Topics: Clinical Trials as Topic; Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine	2017
Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea. Cancer chemotherapy and pharmacology, 2017, Volume: 80, Issue:6 Topics: Administration, Oral; Diarrhea; Female; Humans; Male; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Phenylalanine; Pyrimidines	2017
Advancements in drug development for diarrhea-predominant irritable bowel syndrome. Expert opinion on investigational drugs, 2018, Volume: 27, Issue:3 Topics: Animals; Benzimidazoles; Diarrhea; Drug and Narcotic Control; Drug Design; Gastrointestinal Agents; Humans; Imidazoles; Internationality; Irritable Bowel Syndrome; Phenylalanine	2018
Telotristat Ethyl: A Review in Carcinoid Syndrome Diarrhoea. Drugs, 2018, Volume: 78, Issue:9 Topics: Diarrhea; Drug Interactions; Drug Therapy, Combination; Humans; Malignant Carcinoid Syndrome; Phenylalanine; Pyrimidines; Randomized Controlled Trials as Topic; Signal Transduction; Somatostatin; Treatment Outcome; Tryptophan Hydroxylase	2018
Telotristat ethyl for the treatment of carcinoid syndrome diarrhea not controlled by somatostatin analogues. Drugs of today (Barcelona, Spain : 1998), 2018, Volume: 54, Issue:7 Topics: Clinical Trials as Topic; Diarrhea; Humans; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Phenylalanine; Pyrimidines; Somatostatin	2018
Opioid receptors in the GI tract: targets for treatment of both diarrhea and constipation in functional bowel disorders? Current opinion in pharmacology, 2018, Volume: 43 Topics: Analgesics, Opioid; Animals; Antidiarrheals; Constipation; Defecation; Diarrhea; Gastrointestinal Motility; Gastrointestinal Tract; Humans; Imidazoles; Inflammatory Bowel Diseases; Laxatives; Morphinans; Naltrexone; Narcotic Antagonists; Phenylalanine; Polyethylene Glycols; Quaternary Ammonium Compounds; Receptors, Opioid, mu; Signal Transduction	2018
Chronic diarrhoea in adults: what not to miss. Current opinion in gastroenterology, 2019, Volume: 35, Issue:3 Topics: Adenocarcinoma; Adenoma; Antidiarrheals; Bile Acids and Salts; Celiac Disease; Chronic Disease; Colorectal Neoplasms; Diarrhea; Exocrine Pancreatic Insufficiency; Feces; Gastrointestinal Agents; Humans; Iatrogenic Disease; Imidazoles; Immunochemistry; Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Leukocyte L1 Antigen Complex; Loperamide; Malabsorption Syndromes; Phenylalanine; Steatorrhea	2019
Eluxadoline: First Global Approval. Drugs, 2015, Volume: 75, Issue:11 Topics: Adult; Animals; Diarrhea; Drug Approval; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine; Receptors, Opioid, delta; Receptors, Opioid, mu	2015
Current and emerging drug options in the treatment of diarrhea predominant irritable bowel syndrome. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:18 Topics: Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Loperamide; Phenylalanine; Receptors, Opioid; Rifamycins; Rifaximin	2015
Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron? Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:3 Topics: Abdominal Pain; Anti-Bacterial Agents; Carbolines; Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Narcotic Antagonists; Phenylalanine; Receptors, Opioid; Rifamycins; Rifaximin; Serotonin 5-HT3 Receptor Antagonists	2016
Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS. Neurogastroenterology and motility, 2016, Volume: 28, Issue:1 Topics: Antidiarrheals; Carbolines; Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Loperamide; Pancreatitis; Phenylalanine; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu	2016
Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline. Pharmacotherapy, 2016, Volume: 36, Issue:3 Topics: Administration, Oral; Diarrhea; Disease Management; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin	2016
Eluxadoline for the treatment of diarrhoea-predominant irritable bowel syndrome. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:10 Topics: Abdominal Pain; Constipation; Diarrhea; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine; Receptors, Opioid	2016
Diarrhea-predominant irritable bowel syndrome: Diagnosis, etiology, and new treatment considerations. Journal of the American Association of Nurse Practitioners, 2016, Volume: 28, Issue:7 Topics: Carbolines; Diarrhea; Disease Management; Humans; Imidazoles; Irritable Bowel Syndrome; Parasympatholytics; Phenylalanine; Rifamycins; Rifaximin; United States	2016
New treatment options for irritable bowel syndrome with predominant diarrhea. Current opinion in endocrinology, diabetes, and obesity, 2017, Volume: 24, Issue:1 Topics: Anti-Bacterial Agents; Constipation; Diarrhea; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Narcotic Antagonists; Phenylalanine; Quality of Life; Receptors, Opioid; Rifamycins; Rifaximin	2017
LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin. Neurogastroenterology and motility, 2011, Volume: 23, Issue:3 Topics: Animals; Biphenyl Compounds; Clinical Trials as Topic; Diarrhea; Double-Blind Method; Gastrointestinal Tract; Humans; Irritable Bowel Syndrome; Phenylalanine; Receptors, Serotonin; Serotonin; Tryptophan Hydroxylase	2011
Pharmacology of the carcinoid syndrome. Lancet (London, England), 1968, Feb-24, Volume: 1, Issue:7539 Topics: 5-Hydroxytryptophan; Bradykinin; Diarrhea; Drug Synergism; Humans; Kinins; Malignant Carcinoid Syndrome; Methysergide; Neurologic Manifestations; Phenylalanine; Prostaglandins; Serotonin; Serotonin Antagonists; Skin Manifestations	1968
Progress report: the carcinoid syndrome. Gut, 1970, Volume: 11, Issue:2 Topics: 5-Hydroxytryptophan; Antineoplastic Agents; Bradykinin; Diarrhea; Heart Valve Diseases; Humans; Hydroxyindoleacetic Acid; Kallikreins; Liver Neoplasms; Malignant Carcinoid Syndrome; Methyldopa; Methysergide; Neoplasm Metastasis; Phenoxybenzamine; Phenylalanine; Serotonin	1970

Trials

16 trial(s) available for phenylalanine and Diarrhea

Article	Year
Effects of treatment with eluxadoline on abdominal pain in patients with IBS-D: Additional post hoc analyses of Phase 3 trials. Neurogastroenterology and motility, 2020, Volume: 32, Issue:4 Topics: Abdominal Pain; Adult; Aged; Diarrhea; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Male; Middle Aged; Phenylalanine; Treatment Outcome	2020
Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies. Alimentary pharmacology & therapeutics, 2017, Volume: 45, Issue:10 Topics: Adult; Diarrhea; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Male; Middle Aged; Phenylalanine; Prognosis; Retrospective Studies; Time Factors	2017
Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use. The American journal of gastroenterology, 2017, Volume: 112, Issue:6 Topics: Abdominal Pain; Adult; Antidiarrheals; Diarrhea; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Loperamide; Male; Middle Aged; Pain Measurement; Phenylalanine; Symptom Assessment	2017
Understanding the Patient Experience with Carcinoid Syndrome: Exit Interviews from a Randomized, Placebo-controlled Study of Telotristat Ethyl. Clinical therapeutics, 2017, Volume: 39, Issue:11 Topics: Diarrhea; Double-Blind Method; Female; Humans; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Pyrimidines; Treatment Outcome	2017
Telotristat ethyl in carcinoid syndrome: safety and efficacy in the TELECAST phase 3 trial. Endocrine-related cancer, 2018, Volume: 25, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Diarrhea; Double-Blind Method; Female; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Pyrimidines; Somatostatin; Treatment Outcome	2018
Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome. Clinical therapeutics, 2018, Volume: 40, Issue:6 Topics: Aged; Body Weight; Diarrhea; Double-Blind Method; Female; Humans; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Pyrimidines; Treatment Outcome; Tryptophan Hydroxylase	2018
Relationship Between Symptoms and Health-related Quality-of-life Benefits in Patients With Carcinoid Syndrome: Post Hoc Analyses From TELESTAR. Clinical therapeutics, 2018, Volume: 40, Issue:12 Topics: Aged; Diarrhea; Double-Blind Method; Female; Humans; Male; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Phenylalanine; Pyrimidines; Quality of Life; Treatment Outcome; Tryptophan Hydroxylase	2018
TELEPRO: Patient-Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World. The oncologist, 2019, Volume: 24, Issue:11 Topics: Aged; Cohort Studies; Diarrhea; Female; Follow-Up Studies; Humans; International Agencies; Male; Malignant Carcinoid Syndrome; Patient Reported Outcome Measures; Phenylalanine; Prognosis; Pyrimidines	2019
Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study. The American journal of gastroenterology, 2019, Volume: 114, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diarrhea; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Loperamide; Male; Middle Aged; Phenylalanine; Prospective Studies	2019
Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study. Gastroenterology, 2013, Volume: 145, Issue:2 Topics: Adult; Diarrhea; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Male; Middle Aged; Phenylalanine; Receptors, Opioid, delta; Receptors, Opioid, mu; Treatment Outcome	2013
Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide. Endocrine-related cancer, 2014, Volume: 21, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Diarrhea; Female; Gastrointestinal Agents; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Octreotide; Phenylalanine; Pyrimidines; Serotonin Antagonists; Treatment Outcome	2014
Eluxadoline for Irritable Bowel Syndrome with Diarrhea. The New England journal of medicine, 2016, Jan-21, Volume: 374, Issue:3 Topics: Abdominal Pain; Adult; Aged; Diarrhea; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Irritable Bowel Syndrome; Male; Middle Aged; Pancreatitis; Phenylalanine	2016
[A new remedy for diarrheal irritable bowel syndrome]. MMW Fortschritte der Medizin, 2016, Mar-17, Volume: 158, Issue:5 Topics: Diarrhea; Drug Approval; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine; United States	2016
Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview Approach. Clinical therapeutics, 2016, Volume: 38, Issue:4 Topics: Aged; Antineoplastic Agents; Diarrhea; Female; Humans; Interviews as Topic; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Pyrimidines; Treatment Outcome	2016
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Volume: 35, Issue:1 Topics: Aged; Antineoplastic Agents, Hormonal; Defecation; Diarrhea; Double-Blind Method; Female; gamma-Glutamyltransferase; Gastrointestinal Agents; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Nausea; Octreotide; Peptides, Cyclic; Phenylalanine; Pyrimidines; Somatostatin; Tryptophan Hydroxylase	2017
Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea. The American journal of gastroenterology, 2017, Volume: 112, Issue:2 Topics: Abdominal Pain; Adult; Aged; Constipation; Diarrhea; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Male; Middle Aged; Nausea; Pancreatitis; Phenylalanine; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spasm; Sphincter of Oddi Dysfunction	2017

Other Studies

37 other study(ies) available for phenylalanine and Diarrhea

Article	Year
Delta Variant: Expanding the Indication for Eluxadoline to Bile Acid Diarrhea. Digestive diseases and sciences, 2022, Volume: 67, Issue:8 Topics: Bile Acids and Salts; Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine	2022
Safety and Efficacy of Eluxadoline in Patients with Irritable Bowel Syndrome-Diarrhea With or Without Bile Acid Diarrhea: Open-Label Study. Digestive diseases and sciences, 2022, Volume: 67, Issue:8 Topics: Adult; Bile Acids and Salts; Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine; Quality of Life	2022
Efficacy of Eluxadoline in Irritable Bowel Syndrome With Diarrhea. The American journal of gastroenterology, 2020, Volume: 115, Issue:3 Topics: Diarrhea; Humans; Imidazoles; Irritable Bowel Syndrome; Loperamide; Phenylalanine	2020
Response to Black et al. The American journal of gastroenterology, 2020, Volume: 115, Issue:3 Topics: Diarrhea; Humans; Imidazoles; Irritable Bowel Syndrome; Loperamide; Phenylalanine	2020
Clinical Benefits of Telotristat Ethyl in Patients With Neuroendocrine Tumors and Low Bowel Movement Frequency: An Observational Patient-Reported Outcomes Study. Pancreas, 2020, Volume: 49, Issue:3 Topics: Abdominal Pain; Adolescent; Adult; Aged; Child; Child, Preschool; Defecation; Diarrhea; Female; Flushing; Humans; Infant; Infant, Newborn; Male; Malignant Carcinoid Syndrome; Middle Aged; Nausea; Patient Reported Outcome Measures; Phenylalanine; Pyrimidines; Recovery of Function; Time Factors; Treatment Outcome; Young Adult	2020
Management of irritable bowel syndrome with diarrhea: focus on eluxadoline. Current medical research and opinion, 2021, Volume: 37, Issue:4 Topics: Adult; Aged; Diarrhea; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine	2021
Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide. Journal of managed care & specialty pharmacy, 2021, Volume: 27, Issue:4 Topics: Absenteeism; Adolescent; Adult; Aged; Aged, 80 and over; Diarrhea; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Loperamide; Male; Middle Aged; Phenylalanine; Quality of Life; Surveys and Questionnaires; United States; Young Adult	2021
Telotristat Ethyl: First Global Approval. Drugs, 2017, Volume: 77, Issue:7 Topics: Animals; Diarrhea; Drug Approval; Drug Therapy, Combination; Humans; Malignant Carcinoid Syndrome; Neuroendocrine Tumors; Phenylalanine; Pyrimidines; Randomized Controlled Trials as Topic; Somatostatin; Tryptophan Hydroxylase; United States; United States Food and Drug Administration	2017
Advances in the management of patients with carcinoid syndrome. Clinical advances in hematology & oncology : H&O, 2017, Volume: 15, Issue:4 Topics: Carcinoid Tumor; Clinical Trials, Phase III as Topic; Diarrhea; Humans; Malignant Carcinoid Syndrome; Phenylalanine; Pyrimidines	2017
Telotristat ethyl (Xermelo) for carcinoid syndrome diarrhea. The Medical letter on drugs and therapeutics, 2017, 07-17, Volume: 59, Issue:1525 Topics: Antidiarrheals; Diarrhea; Drug Therapy, Combination; Humans; Malignant Carcinoid Syndrome; Octreotide; Phenylalanine; Pyrimidines; Treatment Outcome	2017
Τ Eluxadoline for IBS-D. Drug and therapeutics bulletin, 2017, Volume: 55, Issue:8 Topics: Contraindications, Drug; Diarrhea; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine	2017
Cost-effectiveness analysis of telotristat ethyl for treatment of carcinoid syndrome diarrhea inadequately controlled with somatostatin analogs. Journal of medical economics, 2018, Volume: 21, Issue:2 Topics: Adult; Aged; Cost-Benefit Analysis; Diarrhea; Drug Costs; Drug Therapy, Combination; Female; Health Resources; Humans; Male; Malignant Carcinoid Syndrome; Markov Chains; Middle Aged; Phenylalanine; Pyrimidines; Quality-Adjusted Life Years; Somatostatin; Treatment Outcome; United States	2018
Safety of Eluxadoline in Patients With Irritable Bowel Syndrome. The American journal of gastroenterology, 2017, Volume: 112, Issue:10 Topics: Diarrhea; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine	2017
Budgetary Impact of Telotristat Ethyl, a Novel Treatment for Patients with Carcinoid Syndrome Diarrhea: A US Health Plan Perspective. Clinical therapeutics, 2017, Volume: 39, Issue:12 Topics: Antidiarrheals; Budgets; Diarrhea; Health Care Costs; Humans; Insurance, Health; Malignant Carcinoid Syndrome; Models, Economic; Phenylalanine; Pyrimidines; Somatostatin; United States	2017
Telotristat ethyl: a novel agent for the therapy of carcinoid syndrome diarrhea. Future oncology (London, England), 2018, Volume: 14, Issue:12 Topics: Diarrhea; Humans; Malignant Carcinoid Syndrome; Phenylalanine; Prevalence; Pyrimidines; Quality of Life; Somatostatin; Treatment Outcome; Tryptophan Hydroxylase	2018
Methylation Products of 6β- N-Heterocyclic Substituted Naltrexamine Derivatives as Potential Peripheral Opioid Receptor Modulators. ACS chemical neuroscience, 2018, 12-19, Volume: 9, Issue:12 Topics: Analgesics, Opioid; Animals; CHO Cells; Constipation; Cricetulus; Diarrhea; Drug Partial Agonism; Gastrointestinal Agents; Gastrointestinal Transit; Imidazoles; Methylation; Mice; Molecular Docking Simulation; Morphine; Naltrexone; Narcotic Antagonists; Nociception; Phenylalanine; Quaternary Ammonium Compounds; Radioligand Assay; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu	2018
The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 2019, Volume: 28, Issue:2 Topics: Adult; Diarrhea; Female; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Male; Middle Aged; Phenylalanine; Quality of Life; Surveys and Questionnaires	2019
Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome. Current medical research and opinion, 2019, Volume: 35, Issue:3 Topics: Adult; Aged; Carbolines; Diarrhea; Female; Health Resources; Humans; Imidazoles; Irritable Bowel Syndrome; Middle Aged; Phenylalanine; Quality of Life; Rifaximin	2019
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome. The oncologist, 2019, Volume: 24, Issue:8 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarrhea; Female; Humans; Male; Malignant Carcinoid Syndrome; Middle Aged; Patient Safety; Phenylalanine; Pyrimidines; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome	2019
Safety of Eluxadoline Use. The American journal of gastroenterology, 2019, Volume: 114, Issue:7 Topics: Diarrhea; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine	2019
Response to Lai. The American journal of gastroenterology, 2019, Volume: 114, Issue:7 Topics: Diarrhea; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine	2019
Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome. Clinical therapeutics, 2014, Volume: 36, Issue:5 Topics: Clinical Trials, Phase II as Topic; Diarrhea; Female; Humans; Imidazoles; Irritable Bowel Syndrome; Male; Models, Psychological; Phenylalanine; Psychometrics; Quality of Life; Surveys and Questionnaires	2014
Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers. Biochemical pharmacology, 2014, Dec-01, Volume: 92, Issue:3 Topics: Animals; Arrestins; beta-Arrestins; Castor Oil; Diarrhea; Humans; Imidazoles; Ligands; Loperamide; Male; Mice, Inbred C57BL; Mice, Mutant Strains; Phenylalanine; Protein Multimerization; Receptors, Opioid, delta; Receptors, Opioid, mu; Signal Transduction	2014
Eluxadoline approved for irritable bowel syndrome with diarrhea. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2015, Jul-01, Volume: 72, Issue:13 Topics: Constipation; Diarrhea; Drug Approval; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine; United States; United States Food and Drug Administration	2015
Eluxadoline (Viberzi) for irritable bowel syndrome with diarrhea. The Medical letter on drugs and therapeutics, 2016, Jan-04, Volume: 58, Issue:1485 Topics: Administration, Oral; Adult; Diarrhea; Drug Approval; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine; Receptors, Opioid, mu; United States; United States Food and Drug Administration	2016
Clinical and structural impact of mutations affecting the residue Phe367 of FOXP3 in patients with IPEX syndrome. Clinical immunology (Orlando, Fla.), 2016, Volume: 163 Topics: Diabetes Mellitus, Type 1; Diarrhea; Dimerization; Eczema; Eosinophilia; Fatal Outcome; Forkhead Transcription Factors; Genetic Diseases, X-Linked; Growth Disorders; Hemorrhage; Hepatomegaly; Humans; Hydrophobic and Hydrophilic Interactions; Immune System Diseases; Immunoglobulin E; Infant; Klebsiella Infections; Leukocytosis; Lung Diseases; Male; Meningoencephalitis; Models, Molecular; Mutation; Phenylalanine; Sepsis; Splenomegaly; Thrombocytopenia; Thymus Gland	2016
IBS: Treating IBS with diarrhoea. Nature reviews. Gastroenterology & hepatology, 2016, Volume: 13, Issue:3 Topics: Diarrhea; Female; Humans; Imidazoles; Irritable Bowel Syndrome; Male; Phenylalanine	2016
Board Review Vignette: Irritable Bowel Syndrome. The American journal of gastroenterology, 2016, Volume: 111, Issue:9 Topics: Abdominal Pain; Adult; Anion Exchange Resins; Antidiarrheals; Carbolines; Cholestyramine Resin; Constipation; Diarrhea; Disease Management; Female; Gastrointestinal Agents; Guanylyl Cyclase C Agonists; Humans; Imidazoles; Irritable Bowel Syndrome; Laxatives; Loperamide; Peptides; Phenylalanine; Probiotics; Rifamycins; Rifaximin; Selective Serotonin Reuptake Inhibitors	2016
Eluxadoline Demonstrates a Lack of Abuse Potential in Phase 2 and 3 Studies of Patients With Irritable Bowel Syndrome With Diarrhea. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2017, Volume: 15, Issue:7 Topics: Administration, Oral; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarrhea; Double-Blind Method; Gastrointestinal Agents; Humans; Imidazoles; Irritable Bowel Syndrome; Phenylalanine; Placebos; Randomized Controlled Trials as Topic; Single-Blind Method; Substance-Related Disorders	2017
[Preventive action of phenylalanine on acute intoxication of ochratoxin-A]. Comptes rendus des seances de l'Academie des sciences. Serie D, Sciences naturelles, 1979, Nov-19, Volume: 289, Issue:13 Topics: Animals; Diarrhea; Dose-Response Relationship, Drug; Drug Antagonism; Mice; Ochratoxins; Phenylalanine	1979
The effect of diarrhea on the oxidation of 14C-phenylalanine in piglets receiving diets varying in protein and proline concentration. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 1986, Volume: 50, Issue:3 Topics: Animals; Animals, Suckling; Carbon Radioisotopes; Diarrhea; Dietary Proteins; Male; Oxidation-Reduction; Phenylalanine; Proline; Swine; Swine Diseases	1986
Serotonin now: clinical implications of inhibiting its synthesis with para-chlorophenylalanine. Annals of internal medicine, 1970, Volume: 73, Issue:4 Topics: Adult; Aged; Animals; Behavior; Brain Chemistry; Catechols; Cattle; Depression; Diarrhea; Dogs; Enzyme Precursors; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Rabbits; Rats; Serotonin; Serotonin Antagonists; Sexual Behavior, Animal; Sleep, REM; Testosterone; Tryptophan; Vasomotor System	1970
Gas chromatographic analysis of urinary tyrosine and phenylalanine metabolites in patients with gastrointestinal disorders. Clinica chimica acta; international journal of clinical chemistry, 1971, Volume: 34, Issue:2 Topics: Acrylates; Adult; Bacteria; Benzene Derivatives; Benzoates; Celiac Disease; Child, Preschool; Chromatography, Gas; Cystic Fibrosis; Diarrhea; Diet; Diet Therapy; Enteritis; Gastrointestinal Diseases; Glutens; Humans; Hydroxylation; Infant; Intestine, Small; Intestines; Malabsorption Syndromes; Pancreatin; Phenylacetates; Phenylalanine; Propionates; Time Factors	1971
Quantitative determination of intestinal peptide hydrolase activity using L-amino acid oxidase. Clinica chimica acta; international journal of clinical chemistry, 1971, Volume: 33, Issue:2 Topics: Amino Acid Oxidoreductases; Animals; Celiac Disease; Child; Diarrhea; Dipeptides; Glycoside Hydrolases; Guinea Pigs; Humans; Intestinal Mucosa; Intestines; Isoleucine; Kinetics; Lactose; Leucine; Mathematics; Methionine; Peptide Hydrolases; Peroxidases; Phenylalanine; Proline; Spectrophotometry	1971
Serum alkaline phosphatase activity in cattle. Clinica chimica acta; international journal of clinical chemistry, 1971, Volume: 33, Issue:2 Topics: Abomasum; Aging; Alkaline Phosphatase; Animals; Bone and Bones; Brain; Cattle; Cattle Diseases; Chemical and Drug Induced Liver Injury; Deficiency Diseases; Diarrhea; Duodenum; Female; Hydrogen-Ion Concentration; Isoenzymes; Kidney; Kinetics; Liver; Lung; Mammary Glands, Animal; Nitrophenols; Phenolphthaleins; Phenols; Phenylalanine; Phosphoric Acids; Placenta; Rumen; Spleen; Urea	1971
The carcinoid syndrome: chronic treatment with para-chlorophenylalanine. Annals of internal medicine, 1970, Volume: 72, Issue:6 Topics: Amino Acids; Chlorine; Diarrhea; Dopamine; Heart Valve Diseases; Hepatomegaly; Humans; Hydroxyindoleacetic Acid; Male; Malignant Carcinoid Syndrome; Middle Aged; Neoplasm Metastasis; Phenylalanine	1970
Hypothermia in a patient with carcinoid syndrome during treatment with parachlorophenylalanine. The New England journal of medicine, 1971, Feb-04, Volume: 284, Issue:5 Topics: Body Temperature Regulation; Chlorine; Diarrhea; Humans; Hypothermia; Male; Malignant Carcinoid Syndrome; Middle Aged; Phenylalanine; Serotonin	1971